Blend Vial strength 48 mg Vial
Neuroxelin48 mg Vial
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
Get to know the compound
Neuroxelin, explained simply
A proposed blend oriented toward research on neuroprotection and recovery after brain injury.
Research area
Excitotoxicity, neuroinflammation, and neural repair
How it works
The source discusses parallels with neuroprotective peptides studied against different targets, including NMDA signaling and microglial responses.
Why it matters
It helps distinguish a formulation hypothesis from evidence on related molecules, which may not transfer to this blend.
What has been observed
Studies on neuropeptide classes and analogues are cited; they do not establish a specific clinical effect for Neuroxelin.
Effects and points to consider
Evidence on related peptides does not validate the blend's efficacy, safety, or use in humans.
01 / Vial strength 48 mg Vial
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Total vial mass | 48 mg |
|---|---|
| Final volume | 3 mL |
| Concentration | 16 mg/mL |
| Frequency | once daily |
| Cycle | 8 in standard table |
Standard / Gradual Approach (3 mL = 16 mg/mL)
| Week | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–4 | 500 mcg | 3 units (0.03 mL) |
| Weeks 5–8 | 750 mcg | 4.7 units (0.047 mL) |
Alternative Dosing Tiers
| Tier | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Conservative | 250 mcg | 1.6 units (0.016 mL) |
| Typical | 500 mcg | 3.1 units (0.031 mL) |
| Aggressive | 1000 mcg | 6.3 units (0.063 mL) |
Supplies needed
View on Amazon
Sterile alcohol swabs
SOURCES
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.